COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | COM | 00287Y109 | 965,758 | 14,373,538 | SH | | SOLE | | 14,373,538 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 857,763 | 20,481,442 | SH | | SOLE | | 20,481,442 | 0 | 0 |
Acceleron Pharma, Inc. | COM | 00434H108 | 910 | 28,765 | SH | | SOLE | | 28,765 | 0 | 0 |
Achaogen, Inc. | COM | 004449104 | 603 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 13,500 | 1,523,739 | SH | | SOLE | | 1,523,739 | 0 | 0 |
Acorda Therapeutics, Inc. | COM | 00484M106 | 24,628 | 738,916 | SH | | SOLE | | 738,916 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 1,833 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 5,284 | 299,356 | SH | | SOLE | | 299,356 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 5,388 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 11,114 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Alcobra Ltd. | SHS | M2239P109 | 11,706 | 1,789,871 | SH | | SOLE | | 1,789,871 | 0 | 0 |
Alder Biopharmaceuticals Inc. | COM | 014339105 | 47,233 | 891,688 | SH | | SOLE | | 891,688 | 0 | 0 |
Aldeyra Therapeutics, Inc. | COM | 01438T106 | 1,102 | 142,000 | SH | | SOLE | | 142,000 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,182,706 | 6,542,599 | SH | | SOLE | | 6,542,599 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 1,359 | 11,340 | SH | | SOLE | | 11,340 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 5,426 | 2,205,710 | SH | | SOLE | | 2,205,710 | 0 | 0 |
Anacor Pharmaceuticals, Inc. | COM | 032420101 | 280,722 | 3,625,498 | SH | | SOLE | | 3,625,498 | 0 | 0 |
Aptose Biosciences, Inc. | COM | 03835T200 | 170 | 33,397 | SH | | SOLE | | 33,397 | 0 | 0 |
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 8,310 | 1,197,366 | SH | | SOLE | | 1,197,366 | 0 | 0 |
Array BioPharma Inc. | COM | 04269X105 | 39,529 | 5,482,505 | SH | | SOLE | | 5,482,505 | 0 | 0 |
Arrowhead Research Corp. | COM | 042797209 | 7,218 | 1,009,509 | SH | | SOLE | | 1,009,509 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 1,768 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 4,815 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
aTyr Pharma Inc. | COM | 002120103 | 43,247 | 2,335,125 | SH | | SOLE | | 2,335,125 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 2,130 | 711,499 | SH | | SOLE | | 711,499 | 0 | 0 |
Bellerophon Therapeutics, Inc. | COM | 078771102 | 2,776 | 350,000 | SH | | SOLE | | 350,000 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 89,134 | 4,190,594 | SH | | SOLE | | 4,190,594 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 172,849 | 11,577,299 | SH | | SOLE | | 11,577,299 | 0 | 0 |
BioDelivery Sciences International, Inc. | COM | 09060J106 | 1,672 | 210,021 | SH | | SOLE | | 210,021 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 560,148 | 4,095,247 | SH | | SOLE | | 4,095,247 | 0 | 0 |
Biota Pharmaceuticals, Inc. | COM | 090694100 | 1,719 | 830,440 | SH | | SOLE | | 830,440 | 0 | 0 |
BioTime, Inc. Rights | WARRANTS | 09066L162 | 23 | 20,084 | SH | | SOLE | | 20,084 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 25,442 | 151,105 | SH | | SOLE | | 151,105 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 30,296 | 7,335,692 | SH | | SOLE | | 7,335,692 | 0 | 0 |
Cellectis S.A. | SPONSORED ADR | 15117K103 | 1,804 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 70,341 | 13,553,275 | SH | | SOLE | | 13,553,275 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 404 | 49,064 | SH | | SOLE | | 49,064 | 0 | 0 |
Chimerix, Inc. | COM | 16934W106 | 5,323 | 115,216 | SH | | SOLE | | 115,216 | 0 | 0 |
Clovis Oncology, Inc. | COM | 189464100 | 17,807 | 202,630 | SH | | SOLE | | 202,630 | 0 | 0 |
Concert Pharmaceuticals, Inc. | COM | 206022105 | 7,384 | 495,908 | SH | | SOLE | | 495,908 | 0 | 0 |
Curis, Inc. | COM | 231269101 | 3,567 | 1,077,663 | SH | | SOLE | | 1,077,663 | 0 | 0 |
Cyclacel Pharmaceuticals, Inc. Pfd. Conv. Ex 6% | PFD CONV EX 6% | 23254L207 | 85 | 13,253 | SH | | SOLE | | 13,253 | 0 | 0 |
CytRx Corporation | COM | 232828509 | 4,910 | 1,319,989 | SH | | SOLE | | 1,319,989 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 55,451 | 1,862,019 | SH | | SOLE | | 1,862,019 | 0 | 0 |
Derma Sciences, Inc. | COM | 249827502 | 24,758 | 3,457,841 | SH | | SOLE | | 3,457,841 | 0 | 0 |
Dermira, Inc. | COM | 24983L104 | 1,755 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Discovery Laboratories, Inc. | COM | 254668403 | 2,427 | 3,569,643 | SH | | SOLE | | 3,569,643 | 0 | 0 |
Dyax Corp. | COM | 26746E103 | 210,056 | 7,926,630 | SH | | SOLE | | 7,926,630 | 0 | 0 |
Enanta Pharmaceuticals, Inc. | COM | 29251M106 | 3,390 | 75,357 | SH | | SOLE | | 75,357 | 0 | 0 |
Epizyme, Inc. | COM | 29428V104 | 5,580 | 232,481 | SH | | SOLE | | 232,481 | 0 | 0 |
Five Prime Therapeutics, Inc. | COM | 33830X104 | 478 | 19,247 | SH | | SOLE | | 19,247 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 20,981 | 2,046,967 | SH | | SOLE | | 2,046,967 | 0 | 0 |
Foundation Medicine, Inc. | COM | 350465100 | 707 | 20,892 | SH | | SOLE | | 20,892 | 0 | 0 |
Galapagos NV | SPONSORED ADR | 36315X101 | 19,018 | 369,276 | SH | | SOLE | | 369,276 | 0 | 0 |
Genomic Health Inc. | COM | 37244C101 | 379,545 | 13,657,598 | SH | | SOLE | | 13,657,598 | 0 | 0 |
Gilead Sciences, Inc. | COM | 375558103 | 29,269 | 249,995 | SH | | SOLE | | 249,995 | 0 | 0 |
Halozyme Therapeutics, Inc. | COM | 40637H109 | 43,603 | 1,931,057 | SH | | SOLE | | 1,931,057 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 87,491 | 2,807,784 | SH | | SOLE | | 2,807,784 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM | 45168K306 | 25,862 | 6,970,902 | SH | | SOLE | | 6,970,902 | 0 | 0 |
Ignyta, Inc. | COM | 451731103 | 8,616 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Immune Design Corp. | COM | 45252L103 | 3,076 | 148,937 | SH | | SOLE | | 148,937 | 0 | 0 |
ImmunoGen, Inc. | COM | 45253H101 | 33,368 | 2,320,424 | SH | | SOLE | | 2,320,424 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 1,549,140 | 14,865,559 | SH | | SOLE | | 14,845,559 | 0 | 0 |
Insmed, Inc. | COM | 457669307 | 38,669 | 1,583,490 | SH | | SOLE | | 1,583,490 | 0 | 0 |
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 3,328 | 104,166 | SH | | SOLE | | 104,166 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 97,538 | 6,554,967 | SH | | SOLE | | 6,554,967 | 0 | 0 |
Ironwood Pharmaceuticals, Inc. | COM | 46333X108 | 2,040 | 169,163 | SH | | SOLE | | 169,163 | 0 | 0 |
Isis Pharmaceuticals, Inc. | COM | 464330109 | 3,288 | 57,140 | SH | | SOLE | | 57,140 | 0 | 0 |
Juno Therapeutics, Inc. | COM | 48205A109 | 4,266 | 80,000 | SH | | SOLE | | 80,000 | 0 | 0 |
Karyopharm Therapeutics Inc. | COM | 48576U106 | 5,904 | 216,990 | SH | | SOLE | | 216,990 | 0 | 0 |
Kythera Biopharmaceuticals, Inc. | COM | 501570105 | 29,201 | 387,741 | SH | | SOLE | | 387,741 | 0 | 0 |
La Jolla Pharmaceutical Company | COM | 503459604 | 10,098 | 412,008 | SH | | SOLE | | 412,008 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | COM | 53220K504 | 7,405 | 73,386 | SH | | SOLE | | 73,386 | 0 | 0 |
Lion Biotechnologies, Inc. | COM | 53619R102 | 16,666 | 1,817,429 | SH | | SOLE | | 1,817,429 | 0 | 0 |
Loxo Oncology, Inc. | COM | 548862101 | 1,803 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 11,582 | 305,043 | SH | | SOLE | | 305,043 | 0 | 0 |
Marinus Pharmaceuticals, Inc. | COM | 56854Q101 | 2,320 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Mast Therapeutics, Inc. | COM | 576314108 | 2,307 | 4,707,464 | SH | | SOLE | | 4,707,464 | 0 | 0 |
MediWound Ltd. | ORD SHS | M68830104 | 1,591 | 225,000 | SH | | SOLE | | 225,000 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 88,276 | 2,805,074 | SH | | SOLE | | 2,805,074 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 25,897 | 542,236 | SH | | SOLE | | 542,236 | 0 | 0 |
NeuroDerm Ltd. | ORD SHS | M74231107 | 3,838 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Novavax, Inc. | COM | 670002104 | 21,675 | 1,945,687 | SH | | SOLE | | 1,945,687 | 0 | 0 |
Ohr Pharmaceuticals, Inc. | COM | 67778H200 | 930 | 370,370 | SH | | SOLE | | 370,370 | 0 | 0 |
Omeros Corporation | COM | 682143102 | 17,354 | 964,621 | SH | | SOLE | | 964,621 | 0 | 0 |
Ophthotech Corporation | COM | 683745103 | 1,856 | 35,649 | SH | | SOLE | | 35,649 | 0 | 0 |
Osiris Therapeutics, Inc. | COM | 68827R108 | 9,714 | 499,193 | SH | | SOLE | | 499,193 | 0 | 0 |
Palatin Technologies, Inc. | COM | 696077403 | 1,825 | 2,050,000 | SH | | SOLE | | 2,050,000 | 0 | 0 |
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 32,457 | 4,350,808 | SH | | SOLE | | 4,350,808 | 0 | 0 |
ProQR Therapeutics N.V. | SHS | N71542109 | 16,475 | 988,299 | SH | | SOLE | | 988,299 | 0 | 0 |
Proteon Therapeutics, Inc. | COM | 74371L109 | 3,157 | 176,762 | SH | | SOLE | | 176,762 | 0 | 0 |
Receptos, Inc. | COM | 756207106 | 4,542 | 23,900 | SH | | SOLE | | 23,900 | 0 | 0 |
Repros Therapeutics Inc. | COM | 76028H209 | 13,985 | 1,955,944 | SH | | SOLE | | 1,955,944 | 0 | 0 |
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 1,780 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Sage Therapeutics, Inc. | COM | 78667J108 | 7,665 | 105,000 | SH | | SOLE | | 105,000 | 0 | 0 |
Sangamo BioSciences, Inc. | COM | 800677106 | 35,831 | 3,230,932 | SH | | SOLE | | 3,230,932 | 0 | 0 |
Seattle Genetics, Inc. | COM | 812578102 | 1,494,121 | 30,870,262 | SH | | SOLE | | 30,860,262 | 0 | 0 |
Seres Therapeutics, Inc. | COM | 81750R102 | 5,188 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Spark Therapeutics, Inc. | COM | 84652J103 | 76,084 | 1,262,382 | SH | | SOLE | | 1,262,382 | 0 | 0 |
Stemline Therapeutics, Inc. | COM | 85858C107 | 3,925 | 333,497 | SH | | SOLE | | 333,497 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM | 867328601 | 9,632 | 3,200,000 | SH | | SOLE | | 3,200,000 | 0 | 0 |
Tekmira Pharmaceuticals Corp. | COM | 87911B209 | 2,142 | 180,582 | SH | | SOLE | | 180,582 | 0 | 0 |
Tenax Therapeutics Inc. | COM | 88032L100 | 1,311 | 355,348 | SH | | SOLE | | 355,348 | 0 | 0 |
TG Therapeutics, Inc. | COM | 88322Q108 | 33,246 | 2,003,991 | SH | | SOLE | | 2,003,991 | 0 | 0 |
Threshold Pharmaceuticals, Inc. | COM | 885807206 | 11,819 | 2,925,519 | SH | | SOLE | | 2,925,519 | 0 | 0 |
Ultragenyx Pharmaceuticals | COM | 90400D108 | 12,686 | 123,894 | SH | | SOLE | | 123,894 | 0 | 0 |
UniQure B.V. | SHS | N90064101 | 810 | 30,000 | SH | | SOLE | | 30,000 | 0 | 0 |
Vanda Pharmaceuticals Inc. | COM | 921659108 | 5,201 | 409,881 | SH | | SOLE | | 409,881 | 0 | 0 |
Versartis, Inc. | COM | 92529L102 | 52,305 | 3,436,585 | SH | | SOLE | | 3,436,585 | 0 | 0 |
Vitae Pharmaceuticals, Inc. | COM | 92847N103 | 2,701 | 187,597 | SH | | SOLE | | 187,597 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 19,159 | 872,072 | SH | | SOLE | | 872,072 | 0 | 0 |
XenoPort, Inc. | COM | 98411C100 | 39,898 | 6,508,622 | SH | | SOLE | | 6,508,622 | 0 | 0 |
XOMA Corporation | COM | 98419J107 | 56,972 | 14,683,513 | SH | | SOLE | | 14,683,513 | 0 | 0 |
Zafgen, Inc. | COM | 98885E103 | 9,962 | 287,677 | SH | | SOLE | | 287,677 | 0 | 0 |
ZIOPHARM Oncology, Inc. | COM | 98973P101 | 2,271 | 189,259 | SH | | SOLE | | 189,259 | 0 | 0 |
Zogenix, Inc. | COM | 98978L105 | 16,848 | 10,028,564 | SH | | SOLE | | 10,028,564 | 0 | 0 |
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | 60,049 | 59,583,000 | PRN | | SOLE | | 59,583,000 | 0 | 0 |
Array BioPharma Inc. Notes 3.0% 6/1/2020 | CONV BONDS | 04269XAA3 | 3,780 | 3,000,000 | PRN | | SOLE | | 3,000,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | 149,970 | 22,379,000 | PRN | | SOLE | | 22,379,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | 18,940 | 12,228,000 | PRN | | SOLE | | 12,228,000 | 0 | 0 |
Gilead, Inc. 1.625% 5/1/16 | CONV BONDS | 375558AP8 | 107,926 | 20,944,000 | PRN | | SOLE | | 20,944,000 | 0 | 0 |
Incyte Corporation Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | 478,833 | 40,446,000 | PRN | | SOLE | | 40,446,000 | 0 | 0 |
Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | 529,519 | 259,000,000 | PRN | | SOLE | | 259,000,000 | 0 | 0 |
Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | 567,758 | 274,500,000 | PRN | | SOLE | | 274,500,000 | 0 | 0 |
Medivation, Inc. 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | 75,011 | 33,889,000 | PRN | | SOLE | | 33,889,000 | 0 | 0 |
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | CONV BONDS | 74365AAB7 | 2,606 | 3,423,000 | PRN | | SOLE | | 3,423,000 | 0 | 0 |